HSBA

1,361.6

+1.64%↑

BARC

461.8

+1.01%↑

LLOY

100.5

+0.86%↑

STAN

1,938.5

+2.03%↑

FERG.UK

17,100

+1.6%↑

HSBA

1,361.6

+1.64%↑

BARC

461.8

+1.01%↑

LLOY

100.5

+0.86%↑

STAN

1,938.5

+2.03%↑

FERG.UK

17,100

+1.6%↑

HSBA

1,361.6

+1.64%↑

BARC

461.8

+1.01%↑

LLOY

100.5

+0.86%↑

STAN

1,938.5

+2.03%↑

FERG.UK

17,100

+1.6%↑

HSBA

1,361.6

+1.64%↑

BARC

461.8

+1.01%↑

LLOY

100.5

+0.86%↑

STAN

1,938.5

+2.03%↑

FERG.UK

17,100

+1.6%↑

HSBA

1,361.6

+1.64%↑

BARC

461.8

+1.01%↑

LLOY

100.5

+0.86%↑

STAN

1,938.5

+2.03%↑

FERG.UK

17,100

+1.6%↑

Home・Aktien・ConvaTec Group PLC

ConvaTec Group PLC

Open

BrancheFinanzen

206 2.79

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

199.7

Max

206.4

Schlüsselkennzahlen
By Trading Economics
Einkommen	-34M 71M
Verkäufe	85M 1.3B
KGV Branchendurchschnitt	32.467 41.721
EPS	0.08
Dividendenrendite	3.71
Gewinnspanne	5.575
Angestellte	10,910
EBITDA	57M 338M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+53.7% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	3.71% 4.65%
Nächstes Ergebnis	4. Aug. 2026
Nächstes Ex-Dividendendatum	20. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-1.1B 3.8B
Vorheriger Eröffnungskurs	203.21
Vorheriger Schlusskurs	206

Nachrichtenstimmung

By Acuity

50%

158 / 439 Ranking in Finance

ConvaTec Group PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

ConvaTec Group PLC Prognose

Kursziel

By TipRanks

53.7% Vorteil

12-Monats-Prognose

Durchschnitt 305.4 GBX 53.7%

Hoch 375 GBX

Tief 230 GBX

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ConvaTec Group PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

Buy

Halten

Sell

Basierend auf 11 Analysten, die in den letzten 3 Monaten Aktienbewertungen für ConvaTec Group PLC – Dist abgegeben haben.

Stimmung

By Acuity

158 / 439 Ranking in Finanzen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.